checkAd

     123  0 Kommentare Tauriga Sciences, Inc. Completes Payment for the Entirety of its Initial Production Run of its Pear Bellini Flavor Immune Booster Tauri-Gum Version - Seite 2

    The Company is headquartered in New York City and operates a regional office in Barcelona, Spain.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.    

    DISCLAIMER -- Forward-Looking Statements

    This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

    Contact:

    CONTACT INFORMATION

    Tauriga Sciences, Inc.
    555 Madison Avenue, 5th Floor
    New York, NY  10022
    Chief Executive Officer
    Mr. Seth M. Shaw
    Email:  sshaw@tauriga.com
    cell # (917) 796 9926

    Instagram: @taurigum

    Twitter: @SethMShaw
    Corp. Website:   
    www.tauriga.com

    Lesen Sie auch

    E-Commerce Website:  www.taurigum.com

    Attachment


    Seite 2 von 2


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Tauriga Sciences, Inc. Completes Payment for the Entirety of its Initial Production Run of its Pear Bellini Flavor Immune Booster Tauri-Gum Version - Seite 2 NEW YORK, NY, July 10, 2020 (GLOBE NEWSWIRE) - via NEWMEDIAWIRE - Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” …

    Schreibe Deinen Kommentar

    Disclaimer